Literature DB >> 18427040

Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma.

Naheed R Abbasi1, Molly Yancovitz, Dina Gutkowicz-Krusin, Katherine S Panageas, Martin C Mihm, Paul Googe, Roy King, Victor Prieto, Iman Osman, Robert J Friedman, Darrell S Rigel, Alfred W Kopf, David Polsky.   

Abstract

OBJECTIVE: To determine the utility of the current diameter criterion of larger than 6 mm of the ABCDE acronym for the early diagnosis of cutaneous melanoma.
DESIGN: Cohort study.
SETTING: Dermatology hospital-based clinics and community practice offices. Patients A total of 1323 patients undergoing skin biopsies of 1657 pigmented lesions suggestive of melanoma. MAIN OUTCOME MEASURE: The maximum lesion dimension (diameter) of each skin lesion was calculated before biopsy using a novel computerized skin imaging system.
RESULTS: Of 1657 biopsied lesions, 853 (51.5%) were 6 mm or smaller in diameter. Invasive melanomas were diagnosed in 13 of 853 lesions (1.5%) that were 6 mm or smaller in diameter and in 41 of 804 lesions (5.1%) that were larger than 6 mm in diameter. In situ melanomas were diagnosed in 22 of 853 lesions (2.6%) that were 6 mm or smaller in diameter and in 62 of 804 lesions (7.7%) that were larger than 6 mm in diameter. Conclusion The diameter guideline of larger than 6 mm provides a useful parameter for physicians and should continue to be used in combination with the A, B, C, and E criteria previously established in the selection of atypical lesions for skin biopsy.

Entities:  

Mesh:

Year:  2008        PMID: 18427040     DOI: 10.1001/archderm.144.4.469

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  13 in total

1.  Assessment of the Diameter of Pigmented Skin Lesions With and Without a Ruler.

Authors:  Harshitha Mannam; Andrew Choi; Saya Jacob; Michael Kwa; Shuai Xu; June K Robinson
Journal:  JAMA Dermatol       Date:  2018-02-01       Impact factor: 10.282

2.  Melanoma in situ: a case report from the patient's perspective.

Authors:  Craig A Bauman; Peter Emary; Tyler Damen; Heather Dixon
Journal:  J Can Chiropr Assoc       Date:  2018-04

3.  Melanocytic lesions ≤ 6mm: Prospective series of 481 melanocytic trunk and limb lesions in Brazil.

Authors:  Gabriella Campos-do-Carmo; Aretha Brito Nobre; Tullia Cuzzi; Giuseppe Argenziano; Carlos Gil Ferreira; Luiz Claudio Santos Thuler
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

Review 4.  The most common mistakes on dermatoscopy of melanocytic lesions.

Authors:  Grażyna Kamińska-Winciorek; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

5.  Screening for malignant melanoma-a critical assessment in historical perspective.

Authors:  Wolfgang Weyers
Journal:  Dermatol Pract Concept       Date:  2018-04-30

6.  Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.

Authors:  Brooke E Rosenbaum; Christine N Schafer; Sung Won Han; Iman Osman; Hua Zhong; Nooshin Brinster
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

7.  Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.

Authors:  Qiuying Ma; Huinan Suo; Li Zhu; Yue Qian; Xiaoyan Sun; Jun Xie; Qianru Li; Yangxue Fu; Jun Li; Juan Tao
Journal:  Cancer Med       Date:  2020-05-05       Impact factor: 4.452

8.  Pigmented Lesion Assay for Suspected Melanoma Lesions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

9.  A tiny invasive melanoma: a case report with dermatoscopy and dermatopathology.

Authors:  Gary Pellizzari; Jill Magee; David Weedon; Cliff Rosendahl
Journal:  Dermatol Pract Concept       Date:  2013-04-30

10.  Suspected melanoma only when the lesion is greater than 6mm may harm patients.

Authors:  Renato Santos de Oliveira Filho; Daniel Arcuschin de Oliveira; Murilo Costa Souza; Mariane da Silva; Mireille Darc Cavalcanti Brandão
Journal:  Einstein (Sao Paulo)       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.